Oramed Pharmaceuticals Share Holder Equity 2011-2024 | ORMP
Oramed Pharmaceuticals share holder equity from 2011 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
| Oramed Pharmaceuticals Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $145 |
| 2023 | $163 |
| 2022 | $151 |
| 2021 | $167 |
| 2021 | $117 |
| 2020 | $33 |
| 2019 | $19 |
| 2018 | $31 |
| 2017 | $19 |
| 2016 | $26 |
| 2015 | $25 |
| 2014 | $21 |
| 2013 | $8 |
| 2012 | $0 |
| 2012 | $4 |
| 2011 | $0 |
| 2011 | $4 |
| 2010 | $4 |
| Oramed Pharmaceuticals Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024-12-31 | $145 |
| 2024-09-30 | $156 |
| 2024-06-30 | $176 |
| 2024-03-31 | $166 |
| 2023-12-31 | $163 |
| 2023-09-30 | $148 |
| 2023-06-30 | $151 |
| 2023-03-31 | $150 |
| 2022-12-31 | $151 |
| 2022-09-30 | $153 |
| 2022-06-30 | $153 |
| 2022-03-31 | $162 |
| 2021-12-31 | $167 |
| 2021-11-30 | $171 |
| 2021-09-30 | |
| 2021-08-31 | $117 |
| 2021-06-30 | |
| 2021-05-31 | $69 |
| 2021-03-31 | |
| 2021-02-28 | $49 |
| 2020-11-30 | $28 |
| 2020-08-31 | $33 |
| 2020-05-31 | $34 |
| 2020-02-29 | $16 |
| 2019-11-30 | $17 |
| 2019-08-31 | $19 |
| 2019-05-31 | $22 |
| 2019-02-28 | $25 |
| 2018-11-30 | $29 |
| 2018-08-31 | $31 |
| 2018-05-31 | $17 |
| 2018-02-28 | $20 |
| 2017-11-30 | $23 |
| 2017-08-31 | $19 |
| 2017-05-31 | $20 |
| 2017-02-28 | $21 |
| 2016-11-30 | $24 |
| 2016-08-31 | $26 |
| 2016-05-31 | $31 |
| 2016-02-29 | $33 |
| 2015-11-30 | $23 |
| 2015-08-31 | $25 |
| 2015-05-31 | $21 |
| 2015-02-28 | $22 |
| 2014-11-30 | $24 |
| 2014-08-31 | $21 |
| 2014-05-31 | $22 |
| 2014-02-28 | $23 |
| 2013-11-30 | $7 |
| 2013-08-31 | $8 |
| 2013-05-31 | $4 |
| 2013-02-28 | $5 |
| 2012-12-31 | |
| 2012-11-30 | $6 |
| 2012-08-31 | $4 |
| 2012-05-31 | $2 |
| 2012-02-29 | $2 |
| 2011-11-30 | $3 |
| 2011-09-30 | |
| 2011-08-31 | $4 |
| 2011-06-30 | $0 |
| 2011-05-31 | |
| 2011-03-31 | |
| 2011-02-28 | |
| 2010-12-31 | $0 |
| 2010-11-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.090B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.007B | 27.90 |
| Boston Scientific (BSX) | United States | $155.135B | 38.84 |
| Stryker (SYK) | United States | $149.698B | 31.30 |
| EssilorLuxottica (ESLOY) | France | $129.877B | 0.00 |
| Medtronic (MDT) | Ireland | $110.440B | 16.12 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.984B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.101B | 27.36 |
| ResMed (RMD) | United States | $36.449B | 27.38 |
| GE HealthCare Technologies (GEHC) | United States | $33.384B | 15.85 |
| Agilent Technologies (A) | United States | $32.046B | 21.17 |
| Terumo (TRUMY) | Japan | $27.153B | 35.27 |
| Koninklijke Philips (PHG) | Netherlands | $22.822B | 16.41 |
| Insulet (PODD) | United States | $22.662B | 88.96 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.138B | 12.29 |
| Baxter (BAX) | United States | $15.929B | 11.89 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.591B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.618B | 23.03 |
| Lantheus Holdings (LNTH) | United States | $5.520B | 13.92 |
| Prestige Consumer Healthcare (PBH) | United States | $4.305B | 19.23 |
| Perrigo (PRGO) | Ireland | $3.614B | 9.16 |
| Haemonetics (HAE) | United States | $3.485B | 15.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.459B | 25.51 |
| Envista Holdings (NVST) | United States | $3.066B | 25.48 |
| QuidelOrtho (QDEL) | United States | $2.234B | 15.36 |
| GN Store Nord (GNNDY) | Denmark | $2.150B | 17.81 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.07 |
| AtriCure (ATRC) | United States | $1.599B | 0.00 |
| Neogen (NEOG) | United States | $1.424B | 18.22 |
| AdaptHealth (AHCO) | United States | $1.220B | 12.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.209B | 27.19 |
| BioLife Solutions (BLFS) | United States | $1.045B | 0.00 |
| InMode (INMD) | Israel | $1.023B | 9.37 |
| Phibro Animal Health (PAHC) | United States | $0.966B | 12.35 |
| Evolus (EOLS) | United States | $0.645B | 0.00 |
| CeriBell (CBLL) | United States | $0.636B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.586B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| Valneva SE (VALN) | France | $0.516B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.499B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.443B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.401B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.95 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.279B | 49.60 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.47 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
| ZimVie (ZIMV) | United States | $0.242B | 11.00 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Brainsway (BWAY) | Israel | $0.188B | 49.90 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.51 |
| Quanterix (QTRX) | United States | $0.175B | 0.00 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Jin Medical (ZJYL) | China | $0.129B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Exagen (XGN) | United States | $0.122B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.084B | 10.83 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.065B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.00 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.57 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |